Lantheus Medical Imaging Inc - Strategic SWOT Analysis Review
Lantheus Medical Imaging Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures and commercializes diagnostic imaging agents and products. The company offers commercial products including ultrasound contrast agent and medical radiopharmaceuticals in a range of imaging modalities. Its products include DEFINITY, TechneLite, Xenon-Xe 133, Neurolite, Cobalt, Thallium-201, Quadramet, Cardiolite and Gallium-67. Its product pipeline include Fludeoxyglucose F 18 Injection, DEFINITY LVEF and LMI 1195. The company offers its products to nuclear physicians, internal medicine physicians, radiologists, technologists and sonographers, integrated delivery networks, hospitals, clinics and group practices. Lantheus Medical is headquartered in North Billerica, Massachusetts, the US.
Lantheus Medical Imaging Inc Key Recent Developments
Sep 10,2021: Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting
May 04,2021: Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results
Apr 20,2021: Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time
Feb 25,2021: Lantheus reports fourth quarter and full year 2020 financial results
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures and commercializes diagnostic imaging agents and products. The company offers commercial products including ultrasound contrast agent and medical radiopharmaceuticals in a range of imaging modalities. Its products include DEFINITY, TechneLite, Xenon-Xe 133, Neurolite, Cobalt, Thallium-201, Quadramet, Cardiolite and Gallium-67. Its product pipeline include Fludeoxyglucose F 18 Injection, DEFINITY LVEF and LMI 1195. The company offers its products to nuclear physicians, internal medicine physicians, radiologists, technologists and sonographers, integrated delivery networks, hospitals, clinics and group practices. Lantheus Medical is headquartered in North Billerica, Massachusetts, the US.
Lantheus Medical Imaging Inc Key Recent Developments
Sep 10,2021: Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting
May 04,2021: Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results
Apr 20,2021: Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time
Feb 25,2021: Lantheus reports fourth quarter and full year 2020 financial results
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
SECTION 1 - ABOUT THE COMPANY
Lantheus Medical Imaging Inc - Key Facts
Lantheus Medical Imaging Inc - Key Employees
Lantheus Medical Imaging Inc - Key Employee Biographies
Lantheus Medical Imaging Inc - Major Products and Services
Lantheus Medical Imaging Inc - History
Lantheus Medical Imaging Inc - Locations And Subsidiaries
Head Office
SECTION 2 – COMPANY ANALYSIS
Company Overview
Lantheus Medical Imaging Inc - Business Description
Lantheus Medical Imaging Inc - Corporate Strategy
Lantheus Medical Imaging Inc - SWOT Analysis
SWOT Analysis - Overview
Lantheus Medical Imaging Inc - Strengths
Lantheus Medical Imaging Inc - Weaknesses
Lantheus Medical Imaging Inc - Opportunities
Lantheus Medical Imaging Inc - Threats
Lantheus Medical Imaging Inc - Key Competitors
SECTION 3 – COMPANY’S RECENT DEVELOPMENTS
Sep 10, 2021: Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting
May 04, 2021: Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results
Apr 20, 2021: Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time
Feb 25, 2021: Lantheus reports fourth quarter and full year 2020 financial results
SECTION 4 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
Lantheus Medical Imaging Inc - Key Facts
Lantheus Medical Imaging Inc - Key Employees
Lantheus Medical Imaging Inc - Key Employee Biographies
Lantheus Medical Imaging Inc - Major Products and Services
Lantheus Medical Imaging Inc - History
Lantheus Medical Imaging Inc - Locations And Subsidiaries
Head Office
SECTION 2 – COMPANY ANALYSIS
Company Overview
Lantheus Medical Imaging Inc - Business Description
Lantheus Medical Imaging Inc - Corporate Strategy
Lantheus Medical Imaging Inc - SWOT Analysis
SWOT Analysis - Overview
Lantheus Medical Imaging Inc - Strengths
Lantheus Medical Imaging Inc - Weaknesses
Lantheus Medical Imaging Inc - Opportunities
Lantheus Medical Imaging Inc - Threats
Lantheus Medical Imaging Inc - Key Competitors
SECTION 3 – COMPANY’S RECENT DEVELOPMENTS
Sep 10, 2021: Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting
May 04, 2021: Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results
Apr 20, 2021: Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time
Feb 25, 2021: Lantheus reports fourth quarter and full year 2020 financial results
SECTION 4 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Lantheus Medical Imaging Inc, Key Facts
Lantheus Medical Imaging Inc, Key Employees
Lantheus Medical Imaging Inc, Key Employee Biographies
Lantheus Medical Imaging Inc, Major Products and Services
Lantheus Medical Imaging Inc, History
Lantheus Medical Imaging Inc, Key Competitors
Lantheus Medical Imaging Inc, Key Facts
Lantheus Medical Imaging Inc, Key Employees
Lantheus Medical Imaging Inc, Key Employee Biographies
Lantheus Medical Imaging Inc, Major Products and Services
Lantheus Medical Imaging Inc, History
Lantheus Medical Imaging Inc, Key Competitors